Neurodevelopmental · Full case

ADHD

NICE NG87DSM-5
H
ADHD · Clinical Reasoning Framework v2
GP & SCA · NICE NG87 (2018, updated 2019) · DSM-5
5%Prevalence in children; 2.5% in adults — most common neurodevelopmental diagnosis in UK primary care
≥2 settingsDSM-5 requirement: symptoms in two or more important settings (e.g. school AND home) — gather school information where feasible, without delaying referral
<12 yearsDSM-5: onset of several symptoms before age 12 (not necessarily diagnosis); onset criterion
6 monthsMinimum symptom duration for ADHD diagnosis; BP/pulse and height every 6 months on treatment (weight 3-monthly if aged 10 or under)
Schedule 2Methylphenidate and lisdexamfetamine: prescription valid 28 days; quantity not normally over 30 days' treatment; specialist-initiated
No routine ECGCardiology advice before medication only if NICE cardiac red flags (e.g. exertional syncope, sudden cardiac death in relative <40)
NICE NG87Parent training first-line under 5; from age 5, medication only if significant impairment persists after environmental modifications
GirlsADHD-I (inattentive) predominates in girls — later diagnosis; academic underachievement; anxiety; masking
📋 Clinical Stem — School Difficulties and Attention Problems
A 9-year-old boy referred by his school SENCO with attention difficulties, hyperactivity, and academic underachievement
Sarah Jenkins attends with her son Charlie (9 years), referred by his school SENCO. Charlie is described as bright and enthusiastic but unable to sustain attention, constantly fidgeting, calling out in class, losing equipment, and failing to complete tasks despite clearly understanding the material when engaged one-to-one. At home he cannot finish homework, bounces between activities, and becomes explosively frustrated when asked to stop something he is enjoying. His teacher has completed a Conners 3 questionnaire (teacher score significantly elevated in the inattention and hyperactivity-impulsivity domains). Charlie's paternal uncle has a formal ADHD diagnosis. Sarah has been blaming herself — "I thought he was just naughty; I kept punishing him for things that were not his fault." She is worried about ADHD medication making Charlie "like a zombie" and wants to understand the non-medication pathway.
This stem tests four key clinical skills: recognising the ADHD presentation across both inattentive and hyperactive-impulsive domains; understanding the NICE NG87 stepped approach (environmental modifications and support before medication; parent training first-line under 5); addressing the medication concern directly with accurate information about methylphenidate; and supporting maternal guilt with reframing about neurodevelopmental conditions. The GP must also ensure school-based observations are part of the referral.
Scenario A — Inattentive ADHD in a Girl 12-year-old girl, "dreamy," academically struggling despite good verbal ability, organisational difficulties, forgets to hand in homework, quiet in class. ADHD-I (inattentive presentation) predominates in girls and is diagnosed on average 3 years later than in boys. Less disruptive = less visible = later referral. Anxiety is a very common comorbidity. School may attribute difficulties to anxiety or learning style. Conners teacher rating crucial.
Scenario B — Adult ADHD Presentation 32-year-old woman, self-refers after her son was diagnosed. "I was exactly like him at school — I struggled for years and thought I was stupid." Adult ADHD: NICE NG87 offers lisdexamfetamine or methylphenidate first-line in adults (in children methylphenidate is first-line). ADHD is lifelong — 60% of childhood ADHD persists. Shared Care Agreement needed. Workplace adjustments under the Equality Act (ADHD is a disability if it substantially affects daily function).
Scenario C — ADHD + Tic Disorder (Tourette's) 10-year-old boy with ADHD on methylphenidate — new vocal and motor tics appearing. Methylphenidate may exacerbate tics — historically believed; evidence is mixed. NICE NG87: if tics develop, consider whether they are stimulant-related and whether the tic impairment outweighs the ADHD benefit; if stimulant-related, reduce the dose or consider changing to guanfacine MR (Intuniv, age 5+) — non-stimulant with evidence for both ADHD and tics. Tourette's comorbid with ADHD in ~20%.
Scenario D — ADHD + Anxiety 14-year-old girl with ADHD diagnosis, anxious before starting methylphenidate. Stimulants can worsen anxiety — but ADHD itself causes anxiety (from repeated failure, criticism, and disorganisation). In practice: trial of methylphenidate often reduces anxiety by reducing the ADHD-driven chaos; but if anxiety worsens, seek specialist advice — comorbid anxiety needs individualised assessment, slower titration and more frequent monitoring; no option is universally preferred. NICE NG87: the specialist may titrate more slowly and monitor more closely in comorbid anxiety.
Scenario E — ADHD Medication Holiday Parents of 11-year-old on methylphenidate ask: "Does he need to take it in school holidays and weekends?" Drug holidays for ADHD are not routinely needed; NICE NG87 asks for at least annual specialist review, where trial periods of stopping or reducing the dose are considered. Continuous medication maintains social and emotional learning, not just academic. Growth monitoring important. Structured assessment during a planned drug holiday can help assess whether medication is still needed. Decision should be joint with specialist, child, and family.
Key variables to adapt for Age (under 5 = no medication; adult = lisdexamfetamine or methylphenidate first-line), sex (girls present later with inattentive features), comorbidities (autism, anxiety, tics, learning disability), school type (mainstream vs special needs), parental ADHD (50% heritability), and presence of substance misuse risk in adolescents (individualised specialist choice; safe storage and diversion risk).
Steps:
1
Step 1
History Taking — Open Question First · Two-Setting Screen · DSM-5 Domains · Red Flags · ICE
▲collapse
ADHD history has one absolute structural requirement: symptoms must be present in at least two settings. A child who struggles only at home (but not at school) is unlikely to have ADHD — consider family dynamics, parenting stress, or an undetected learning difficulty. A child who struggles only at school is more likely to have ADHD than previously thought — but anxiety, learning disability, and sensory issues must be excluded. Teacher-completed rating scales (Conners 3, SNAP-IV, NICHQ Vanderbilt) are helpful adjuncts, not NICE-mandated forms: obtain school information where feasible, but do not delay referral solely because a questionnaire is unavailable. No rating scale establishes or excludes ADHD on its own.
🎓 Consultation opener — address the guilt first
"Before we go through everything clinically, I want to say something to you both: the fact that you are here today, asking these questions, and that Charlie's school has been engaged — that is what good parenting looks like. ADHD is a neurodevelopmental condition. It is not caused by parenting, diet, screens, or lack of discipline. If Charlie has ADHD, there is nothing you could have done differently. Nothing."
Parental guilt is almost universal in ADHD presentations — particularly when children have been repeatedly punished for behaviours that were in fact ADHD symptoms. Addressing this explicitly, early, creates the therapeutic alliance needed for the rest of the consultation to be productive.
1A — Open question, then targeted history across both settings
Question to askWhy it matters clinicallyChanges what?
🟢 OPEN QUESTION"Tell me about Charlie in his own words — what is he like at home and at school, what does he find easy and what does he find hard, and what has made you and the school concerned?" The spontaneous narrative reveals inattentive and hyperactive-impulsive features across both settings without prompting. A parent who describes "starting five things and finishing none, losing his pencil case daily, and calling out when he knows the answer but cannot wait" has provided the core ADHD feature set without any clinical leading. The two-setting requirement (school AND home) emerges naturally from an open question that invites both contexts.In SCA: a candidate who starts with "does he fidget?" has skipped the open narrative, missed the opportunity for the parent to share the full psychosocial impact, and potentially missed features that do not fit neatly into a clinical question. Both DSM-5 domains; two-setting confirmationPsychosocial impact; parental stress
Inattentive symptoms — at school"What does Charlie's teacher say about his attention in class? Does he follow multi-step instructions? Does he finish classwork? Is he easily distracted? Does he seem to daydream or zone out?"Inattention at school is the core academic impairment domain. DSM-5 inattentive symptoms (≥6/9 required): fails to give close attention to details; difficulty sustaining attention; does not seem to listen when spoken to directly; does not follow through on instructions; difficulty organising tasks; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful in daily activities. The teacher's rating is the most objective data available — their Conners score has diagnostic weight that the parent's subjective account cannot fully replace.Teacher-completed questionnaires (Conners 3, NICHQ Vanderbilt, SNAP-IV) are useful adjuncts to request alongside the referral — but they are not NICE-mandated, cannot establish or exclude ADHD on their own, and referral should not be delayed waiting for them.Inattentive domain; both settings confirmedConners/SNAP-IV teacher rating requested
Hyperactive-impulsive symptoms"Is Charlie very fidgety — cannot sit still even when he wants to? Does he talk excessively, interrupt others, or call out before questions are finished? Does he act without thinking about consequences?"DSM-5 hyperactive-impulsive symptoms (≥6/9 required): fidgets; leaves seat; runs/climbs inappropriately; unable to play quietly; "on the go"; talks excessively; blurts answers; difficulty waiting turn; interrupts. The combined type (ADHD-C) has both inattentive and hyperactive-impulsive features and is most common in children. The predominantly inattentive type (ADHD-I) presents less obviously — often missed in girls who are quiet but disorganised.Boys tend to present with more hyperactive-impulsive features (more visible, more disruptive) which leads to earlier referral. Girls with ADHD-I present with inattention, daydreaming, organisational failure — often labelled "lazy" or "anxious" before ADHD is considered.ADHD-C vs ADHD-I vs ADHD-HIGirls: lower threshold for ADHD-I referral
Age of onset and duration"When did you first notice these difficulties? Were they present before school started? Has this been going on for at least 6 months?"DSM-5 requires onset of several symptoms before age 12 (not necessarily the full diagnostic picture) and duration ≥6 months. Symptoms that began abruptly after starting secondary school, after a significant life event (bereavement, divorce, bullying), or after a physical illness suggest an acquired rather than neurodevelopmental cause. A parent who says "he has always been like this, since he was a toddler" is providing important diagnostic support.It is important to distinguish ADHD (lifelong, from early childhood, multiple settings) from situational attention problems (school-related anxiety, undiagnosed learning disability presenting when demands exceed ability, social difficulties causing avoidance).Onset before 12 + duration 6 months: DSM-5 satisfiedAcute onset after event: acquired cause; exclude anxiety/depression
Functional impairment — at home and school"How much is this affecting Charlie's daily life — his friendships, his school progress, his family relationships, his sleep, his self-esteem?"Functional impairment in at least two settings is required for ADHD diagnosis — not just symptom presence. A child who has ADHD symptoms but whose academic performance is excellent and who has good friendships does not meet diagnostic criteria for ADHD (though may have subthreshold features worth monitoring). The impairment criterion distinguishes a clinical condition from a personality trait that is simply on the more active end of the normal distribution.Self-esteem is consistently the most impacted domain in undiagnosed ADHD — children who are repeatedly told they are "lazy," "naughty," or "not trying hard enough" when they are in fact neurologically unable to sustain attention develop deep internalised shame. Identifying and naming this is an important therapeutic act.Functional impairment: DSM-5 criterion metSelf-esteem; shame; peer relationships
Comorbidities — systematic screen"Has anyone suggested autism, anxiety, depression, or a learning difficulty? Any sleep problems? Any tics? Any explosive or oppositional behaviour?"ADHD rarely presents in isolation. Major comorbidities: autism spectrum condition (50–70%); anxiety disorder (30–50%); depressive disorder (20%); tic disorder/Tourette's (20%); oppositional defiant disorder (ODD); conduct disorder; developmental coordination disorder (DCD/dyspraxia); dyslexia; sleep disorders. Comorbidities change how treatment is chosen and monitored — comorbid anxiety, tics or substance misuse need individualised specialist assessment, slower titration and more frequent monitoring; no option is universally preferred (NG87 offers people with tics the same medication choices).Oppositional defiant disorder (ODD) and conduct disorder comorbid with ADHD have a significantly worse prognosis if untreated. These children are at higher risk of school exclusion, criminal justice involvement, and substance misuse in adolescence. Urgent, comprehensive specialist management is indicated.Comorbidities → medication choice changesODD/CD: urgent specialist + CAMHS input
Family history of ADHD"Does ADHD, attention problems, or learning difficulties run in the family? Has any parent or sibling been assessed? Does either parent recognise themselves in Charlie's description?"ADHD has a heritability of ~76% — one of the highest among common mental health conditions. A parent who says "that's exactly like me at school — I struggled my whole life and never knew why" is providing significant diagnostic support AND identifying an undiagnosed adult who may need their own assessment. Paternal uncle with ADHD (as in Charlie's case) is directly relevant family history.Adult ADHD is significantly underdiagnosed — particularly in women. A parent who recognises themselves in their child's description has a 40–50% chance of having ADHD themselves. Offering an adult ADHD screen (e.g. Adult ADHD Self-Report Scale, ASRS-v1.1) at the same appointment is clinically appropriate and genuinely helpful.FH supports ADHD diagnosisParent with possible ADHD: adult ADHD assessment pathway
School history and current educational support"What school does Charlie attend? Has the SENCO been involved? Is there a SEND Support Plan? Has the school completed any formal observations?"School engagement is diagnostic and therapeutic. The SENCO's observations are valuable supporting information for the specialist assessment. Request teacher rating scales where feasible and attach them if available — but do not hold the referral back waiting for them.ADHD is a special educational need under the SEND Code of Practice — schools have statutory duties to make reasonable adjustments even without a formal diagnosis. Advising parents to involve the SENCO immediately — before the specialist appointment — ensures that support begins now, not in 12 months.Teacher Conners/SNAP-IV rating scales: request nowSENCO engagement: SEND Support Plan immediately
Sleep history"How does Charlie sleep? Does he struggle to switch off at night? What time does he naturally fall asleep? Is he tired and irritable during the day?"Sleep disorders are extremely common in ADHD — both as a primary feature of the neurodevelopmental condition (circadian rhythm dysregulation; difficulty transitioning to sleep) and as a side effect of stimulant medication (delayed sleep onset from evening medication). Poor sleep amplifies all ADHD symptoms and creates a diagnostic confounder — a sleep-deprived child without ADHD can appear inattentive and hyperactive. Both conditions may coexist. Melatonin is used for ADHD-associated sleep disorders (off-label for non-autism sleep in children).ADHD and sleep: it can be genuinely difficult to know which came first. A sleep diary is a useful pre-referral tool — it establishes baseline sleep patterns and identifies whether a primary sleep disorder might be responsible for or contributing to the attention difficulties.Sleep disorder: melatonin; sleep hygiene programmeSleep deprivation mimicking or amplifying ADHD
Dietary, screen, and lifestyle history (accurately)"Has diet or screen time been raised as a possible cause? What does Charlie eat and drink typically? What are his screen habits?"Common parental concerns that require accurate, evidence-based responses: (1) Sugar causes ADHD — not supported by evidence; elimination of sugar does not treat ADHD. (2) Screens cause ADHD — screens do not cause ADHD; ADHD causes preference for highly stimulating, rapidly changing visual input (screens). (3) Omega-3 supplements — studied, but not recommended by NICE NG87 for ADHD. The GP corrects these beliefs with kindness — not dismissiveness.Red food dyes: there is weak evidence that artificial food colourings may slightly worsen hyperactivity in some children (not just those with ADHD). NICE NG87: do not advise eliminating artificial colourings and additives as a general treatment; ask about foods or drinks that seem to affect behaviour, and if there is a clear link suggest a food and behaviour diary, with dietitian referral if it supports the link.Diet myth correction; parental anxiety about causationOmega-3: studied but not recommended (NG87)
1B — Red flags: do not attribute these to ADHD alone
🚨

Red Flags — investigate before assuming ADHD

Red flagWhy importantAction
Acute onset of attention difficulties following a significant stressor (bereavement, abuse, parental separation)ADHD is lifelong and neurodevelopmental — it does not begin in response to stress. Acute-onset inattention after a life event suggests reactive depression, PTSD, or adjustment disorder. These require mental health referral, not ADHD assessment. Treating depression or anxiety may fully resolve the attention symptoms.CAMHS referral for acute-onset; PHQ-A; safeguarding screen
Seizures, absence episodes, or unexplained staring spellsAbsence epilepsy (petit mal) is frequently misdiagnosed as ADHD — both cause inattention, "zoning out," and apparent daydreaming. The distinction: absence seizures have abrupt onset and offset, associated eye blinking or automatisms, and last 5–30 seconds. EEG is diagnostic. Treating absence epilepsy as ADHD is dangerous.Paediatric neurology referral; EEG is specialist-arranged
Significant mood episode (elevated, expansive, or persistently depressed mood)Bipolar disorder (rare in children but occurs) can present with hyperactivity, impulsivity, and inattention — but with episodes of abnormally elevated mood, grandiosity, and dramatically reduced need for sleep. Stimulant medication in undiagnosed bipolar can precipitate a manic episode. CAMHS assessment required before any ADHD medication.CAMHS urgent assessment before medication
Visual or hearing impairment (undetected)A child who cannot see the board or cannot hear the teacher clearly will appear inattentive, distracted, and under-achieving. Vision and hearing must be checked before ADHD referral. Treating undetected sensory impairment may resolve the apparent ADHD entirely.Vision test; formal audiology; before referral
Safeguarding concerns — chaotic or abusive home environment, possible emotional neglectAdverse childhood experiences (ACEs) — abuse, neglect, domestic violence, parental mental illness — produce hypervigilance, impulsivity, and emotional dysregulation that closely mimics ADHD. Children from high-ACE environments have significantly higher ADHD rates, but also have ADHD-like presentations from trauma alone. Both can coexist.Safeguarding assessment; CAMHS; trauma-informed approach
🛡️

Safeguarding Considerations

⚠️ ADHD and School Exclusion
  • Children with ADHD are 3× more likely to be excluded from school than their neurotypical peers
  • School exclusion disproportionately affects undiagnosed autistic and ADHD children — behaviour that results from a neurodevelopmental condition is being disciplined as a moral failing
  • GP advocacy letter to school can be legally protective — "this child's behaviour is a manifestation of a medical condition that is currently being assessed"
  • Fixed-term exclusions for ADHD-related behaviour should trigger an emergency EHCP review
🏠 ACEs and Trauma-Mimicking ADHD
  • Adverse childhood experiences (domestic violence, abuse, neglect, parental substance misuse) produce ADHD-like symptoms through traumatic hypervigilance and dysregulation
  • A child from a high-ACE environment may have ADHD, trauma symptoms, or both — the presentation is similar; the treatment is different
  • NICE NG87: consider whether there is a safe and stable home environment before initiating medication; highly chaotic environments require social care involvement
  • Safeguarding check at every ADHD consultation — not just at the first presentation
💊 Medication Misuse Risk (Adolescents)
  • Methylphenidate and lisdexamfetamine are Schedule 2 controlled drugs with misuse potential — both by the patient and by family members or peers
  • ADHD itself is associated with higher rates of substance misuse in adolescence (self-medicating with stimulants, cannabis, alcohol)
  • If substance misuse is present or suspected: individualised specialist choice with closer monitoring — non-stimulants are not CDs and the specialist may prefer lisdexamfetamine (a pro-drug) or a non-stimulant, but no option is universally preferred
  • Monthly controlled drug prescriptions: document supply and patient/family agreement to safeguard medication
👪 Parental ADHD and Family Function
  • 50% heritability: if Charlie has ADHD, there is a significant chance at least one parent has it. Undiagnosed parental ADHD significantly impairs the parent's ability to implement behavioural strategies consistently
  • A parent with undiagnosed ADHD cannot reliably run a behaviour programme — this is not a parenting failure, it is a medical reality
  • Screen both parents with ASRS-v1.1 at the initial appointment; offer adult ADHD assessment if score elevated
  • Parental ADHD affects employment, finances, and relationship stability — all safeguarding-relevant
If safeguarding concerns: School exclusion without EHCP → SENCO involvement + GP advocacy letter. High-ACE environment → social care referral alongside CAMHS. Adolescent substance misuse → specialist advice on medication choice; substance misuse counselling. Parental ADHD suspected → adult ADHD referral; parenting support programme.
1C — PMH · Drug history · Family and social history
🧬 PMH / Family history
FactorWhy it mattersManagement impact
Autism spectrum condition (ASC)50–70% of autistic children also have ADHD; ADHD-ASC comorbidity is extremely common. Methylphenidate may be less effective in autism; comorbid anxiety needs individualised specialist assessmentSpecialist assessment for both; combined management plan. Methylphenidate with caution. School support for dual diagnosis.
Anxiety or depressionBoth cause inattention and impaired concentration mimicking ADHD. Can coexist. ADHD itself causes secondary anxiety (from repeated failure). Stimulants can worsen primary anxiety disorderComorbid anxiety: the specialist may titrate more slowly and monitor more closely (NICE NG87). If anxiety worsens on a stimulant: specialist advice — slower titration, closer monitoring; no option universally preferred. CBT for anxiety regardless of ADHD diagnosis.
Tic disorder / Tourette's syndrome20% of ADHD children have tics. Stimulants may worsen tics (evidence mixed — do not routinely withhold). If tics significantly worsen: guanfacine MR (Intuniv) has evidence for both ADHD and ticsMonitor tics closely after starting stimulant. If tics worsen significantly: seek specialist advice (guanfacine is a specialist option in children and young people). Specialist Tourette's and ADHD co-management.
Family history of ADHD (parent, sibling, first-degree relative)76% heritability — strongest genetic signal in psychiatry. FH strengthens diagnostic probability. May indicate undiagnosed parent needing own assessmentScreen both parents with ASRS-v1.1. Adult ADHD assessment pathway if elevated. Parental ADHD affects ability to implement behaviour strategies.
Cardiac disease, arrhythmia, or structural heart defectStimulants (methylphenidate, lisdexamfetamine) increase BP and HR. Contraindicated in significant structural heart disease, uncontrolled arrhythmia, or serious cardiomyopathyNo routine ECG. Cardiology advice before medication if NICE cardiac red flags (congenital heart disease, sudden cardiac death in a first-degree relative under 40, exertional syncope or breathlessness, palpitations, cardiac chest pain, murmur, hypertension). Atomoxetine or guanfacine if stimulant contraindicated.
💊 Drug and social history
FactorWhy it mattersImpact
Current medicationsAny stimulant-like drugs (decongestants, pseudoephedrine) can worsen cardiovascular effects of methylphenidate. Antidepressants (TCAs, MAOIs) interact with stimulants. Antiepileptics may reduce stimulant efficacyFull drug reconciliation before prescribing. MAOIs: absolute CI with stimulants (hypertensive crisis). TCAs: monitor BP closely.
Substance misuse (adolescents)Cannabis, stimulant drugs, and alcohol use in adolescents with untreated ADHD — partly self-medicating. Methylphenidate and lisdexamfetamine have misuse potential; can be diverted to peersSpecialist individualises the choice in a substance misuse setting, with closer monitoring. Monthly prescriptions only. Safe storage discussion with family.
Dietary pattern and weightStimulants suppress appetite — risk of weight loss and growth restriction. Baseline weight and height centile essential before starting. Particularly relevant in children already underweight or with restricted eatingPlot height and weight on centile chart. Height every 6 months; weight every 3 months if aged 10 or under (NG87). Offer breakfast before morning dose to reduce appetite suppression at lunchtime.
School type and support levelMainstream vs special school; EHCP vs SEND Support Plan; degree of TA support available. The school environment and support determine the degree of functional impairment and what non-pharmacological interventions are feasibleSENCO engagement from day one. Teacher rating scales requested before referral. EHCP application initiated if significant impairment.
1D — ICE: Ideas · Concerns · Expectations
💡 Why ICE matters in ADHD — the medication fear and the guilt

Two psychological barriers dominate the ADHD consultation with parents: (1) the fear that ADHD medication will change their child's personality ("zombie effect") — driven by online misinformation and anecdotal horror stories; and (2) parental guilt at having punished a child for behaviours that were neurologically determined rather than wilfully disobedient. Both barriers must be addressed directly, with evidence and empathy, for the family to engage meaningfully with the management plan. A parent who leaves believing medication will sedate their child will not give consent for treatment even if the diagnosis is confirmed.

💭 Ideas
"What do you understand about ADHD from what you have read or heard? Do you have a sense of what is causing Charlie's difficulties?"
Parents who have self-researched ADHD online have often encountered both accurate information and significant misinformation (sugar causes ADHD; screens cause ADHD; vaccines cause ADHD; medication turns children into zombies). Identifying the specific ideas the parent holds allows the GP to provide accurate, targeted correction rather than generic information.
😟 Concerns
"What worries you most about today — the assessment process, the possibility of a diagnosis, or what might happen if medication is recommended?"
The medication concern is nearly universal and must be addressed directly. "I don't want Charlie to become a zombie or lose his personality" is the most common fear. The accurate clinical response: methylphenidate at appropriate doses enhances the child's ability to engage their existing personality, rather than suppressing it. The "zombie" effect is a sign of over-dosing — the dose needs reducing, not stopping.
🎯 Expectations
"What were you hoping would happen today — a referral, information about what ADHD is, or something else?"
Most parents attending with an ADHD concern want a clear pathway: referral to the right service, with the right information to take with them. Some specifically want reassurance that they have not caused this. Some want to know if medication is inevitable. Understanding the expectation allows the GP to meet it or explain an alternative pathway without the parent feeling dismissed.
1E — Psychosocial context
😔 Parental Guilt and Self-Blame

Mothers of ADHD children have been told — by family members, teachers, and occasionally by professionals — that the child's behaviour reflects poor parenting. The cumulative effect is profound guilt, shame, and self-doubt. Addressing this explicitly and authoritatively ("this is a neurological condition, not a parenting outcome") is the most therapeutically significant statement in this consultation. It also prevents parents from withholding consent for treatment out of unresolved shame.

"I want to be direct with you: ADHD is a neurodevelopmental condition with a very strong genetic basis. It is not caused by parenting, by screens, by diet, or by anything you did. The challenges Charlie has been experiencing are not his fault, and they are not yours."
📚 Academic Impact and Self-Esteem

Charlie has been described as "clearly bright" but failing academically. This mismatch — between visible intelligence and academic performance — is perhaps the most painful ADHD experience for children and parents alike. The child has been repeatedly told they are not trying, not bright enough, not good enough. The accumulated shame is often the most important clinical target in ADHD treatment — more immediately damaging than the inattention itself.

"Charlie is not failing because he is not bright enough. He is failing because his brain has difficulty sustaining attention and managing impulses without support. The right support will allow the ability you can already see in him to show up in school."
👫 Peer Relationships and Social Difficulty

ADHD impairs social relationships through impulsivity (interrupting, acting before thinking, invading personal space), emotional dysregulation (explosive reactions that frighten peers), and poor turn-taking. Children with ADHD are rejected by peers more quickly than any other diagnostic group. Social isolation and bullying are common consequences. These social failures compound the shame spiral and are important targets for behavioural intervention.

"Have there been any problems with friendships — children not wanting to play with Charlie, or Charlie falling out with friends more than you would expect? The social difficulties from ADHD can be just as impactful as the academic ones."
🏠 Family Stress and Sibling Impact

Raising a child with undiagnosed and unsupported ADHD is exhausting. The chaos of daily ADHD life — homework battles, lost possessions, explosive arguments, school complaints — creates family-wide stress. Siblings may feel overlooked or may model the ADHD behaviour. The parent with undiagnosed ADHD may be unable to implement behavioural strategies consistently. Family wellbeing is a clinical priority, not an afterthought.

"How is the rest of the family coping — how is this affecting your household day-to-day? And how is his sibling doing through all of this?"
💼 Parental Employment and ADHD

Parents of ADHD children report significantly higher rates of work disruption — attending school calls, managing crises, attending appointments. If the parent themselves has ADHD (highly likely at 50% heritability), their own occupational difficulties are relevant. Signpost to ADHD UK (adhduk.org) and CHADD equivalent resources for adults who recognise themselves in the description.

"As you describe Charlie, I want to check — do you recognise any of these patterns in yourself? Some parents find, when their child is assessed, that they start to understand their own experiences in a new way."
🔮 Prognosis — ADHD is Lifelong but Manageable

60% of childhood ADHD persists into adulthood. Many adults with treated ADHD lead highly successful lives — ADHD is associated with creativity, entrepreneurship, hyperfocus, and high energy when channelled effectively. The prognosis with treatment is good; the prognosis without treatment (school failure, substance misuse, employment difficulties, relationship breakdown) is significantly worse. Framing ADHD as a manageable condition rather than a life sentence is therapeutically important.

"With the right support, children with ADHD go on to achieve whatever they set their minds to. Many of the most successful and creative people describe ADHD as part of who they are. The diagnosis is a starting point for getting Charlie the support that will allow him to flourish."
🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills
Key phrases that score
"ADHD is a neurodevelopmental condition — it is not caused by parenting, screens, or diet. If Charlie has ADHD, there is nothing you could have done differently."
"I will make the referral now, and I would also like to ask the school to complete a rating scale — it helps the specialist, but we will not wait for it before referring."
"On the medication question — methylphenidate does not change a child's personality when used at the right dose. It helps the brain regulate its attention, which actually allows the child's real personality to come through more fully."
Deductions
  • Not addressing parental guilt and self-blame explicitly
  • Not asking about the school setting — single-setting presentation does not satisfy DSM-5
  • Not requesting school information (e.g. teacher rating scales) alongside the referral
  • Confirming the food/screen/sugar myth without challenging it
  • Not addressing the medication fear directly and accurately
🔴 Red
Parental guilt not addressed; single setting only; teacher scales not mentioned; medication fear not addressed; sugar/screen myth reinforced; no ICE; red flags not screened
🟠 Amber
Two settings confirmed but teacher scales not requested; parental guilt acknowledged but not corrected; medication fear noted but not addressed with evidence; ICE partial; comorbidities not screened
🟢 Green
Parental guilt addressed with neurodevelopmental framing; both settings confirmed; teacher rating scales requested; medication concern addressed accurately ("the zombie effect is over-dosing, not dosing"); ICE all three; comorbidities screened; family history (FH ADHD, FH sudden cardiac death for cardiology-advice decision); two-setting two-domain clinical picture; closing question
2
Step 2
Triage Engine — Emergency · Urgent · Routine
▲collapse
ADHD triage determines urgency based on functional impairment, risk, and comorbidities. Uncomplicated ADHD in a school-age child with school engagement is routine. ADHD with significant risk (exclusion, substance misuse, safeguarding concerns, comorbid conduct disorder) is urgent. Comorbidities that require exclusion before any ADHD management (absence epilepsy, bipolar disorder, severe mental health) require same-day or urgent assessment.
🔴 Urgent — act within days

Same-Day to 2 Weeks

Risk present — do not manage as routine
  • Absence episodes, staring spells, or possible seizuresPaediatric neurology referral (EEG specialist-arranged) before any ADHD treatment — absence epilepsy mimics ADHD; stimulants may lower seizure threshold
  • ADHD + significant mood episode (possible bipolar)Urgent CAMHS — stimulants can precipitate mania in undiagnosed bipolar; full psychiatric assessment before medication
  • ADHD + school exclusion + conduct disorderUrgent CAMHS + EHCP emergency review + social care involvement — conduct disorder + ADHD = highest risk for criminalisation without urgent intervention
  • Safeguarding concern + chaotic environmentChildren's social care referral + CAMHS — ADHD assessment valid but safe and stable environment required before medication initiation
🟠 Expedited

Weeks — Accelerated Pathway

School risk; parent ADHD
  • School exclusion imminent or repeated fixed-term exclusionsGP advocacy letter to school; SENCO emergency EHCP review; expedited CAMHS referral
  • Parental ADHD suspected alongside child presentationAdult ADHD assessment pathway (ASRS-v1.1 screen); parent needs own support before they can implement behavioural strategies
  • Significant substance misuse in adolescent with ADHD featuresExpedited CAMHS + substance misuse referral; medication choice individualised by the specialist
🟢 Routine

Standard ADHD Assessment Pathway

CAMHS / paediatrics
  • Suspected ADHD — symptoms in two settings, no urgent featuresCAMHS or community paediatrics referral with teacher rating scales (Conners 3 / SNAP-IV) attached where available — do not delay for them; SENCO engaged; parenting programme initiated if mild-moderate
  • Mild-moderate ADHD features — under 5 or mild impairmentADHD-focused group parent training first-line under 5 (NICE NG87); from 5, support and environmental modifications before medication
  • Review of existing ADHD diagnosis — medication titrationGP shared care; specialist titration; BP/HR and height 6-monthly, weight at NICE age-specific intervals
🎓 SCA Checkpoint — Step 2Tasks
Triage rationale
"My plan is to refer Charlie to the CAMHS/paediatrics team for a full ADHD assessment. I will send the referral now, and I would also like to ask the school to complete a rating scale — it will help the specialist, but we will not hold the referral back waiting for it."
Deductions
  • Referring without requesting teacher rating scales
  • Not screening for absence epilepsy before assuming ADHD
  • Initiating methylphenidate in primary care without specialist assessment
3
Step 3
Do I Need This Examination?
▲collapse
The GP examination in ADHD has two purposes: excluding physical causes of ADHD-like symptoms (thyroid disease, anaemia, hearing/vision impairment) and establishing baselines before medication (BP, HR, height, weight). There is no physical sign that confirms or excludes ADHD — the diagnosis is clinical, based on history and rating scales.
ExaminationWhy it mattersFinding that changes managementChanges?
BP and HR (both arms if cardiac concern)Baseline BP and HR are mandatory before stimulant medication — methylphenidate increases both. Hypertension or tachycardia at baseline must be investigated before stimulant initiation. Provides the monitoring baseline for all future reviews.NICE NG87: record BP, HR, height, and weight before medication and at each review. Without a documented baseline, the significance of any change on medication cannot be assessed.Baseline hypertension or tachycardia → investigate before stimulant; cardiology referral if significant. Normal → document as baseline; initiate stimulant if specialist recommends.YES — mandatory pre-treatment baseline
Height and weight (plotted on centile chart)Stimulants suppress appetite — risk of growth restriction and weight loss over time. Baseline centile essential to detect any growth faltering on medication. Children who are already below the 9th centile require particular vigilance.Below 9th centile at baseline → specialist discussion before stimulant; dietitian review. Growth faltering on medication → dose reduction / drug holiday / dietary support.YES — mandatory baseline; height 6-monthly, weight per NICE age intervals on treatment
Vision test (acuity)Undetected visual impairment causes inattention, academic difficulties, and apparent ADHD. A child who cannot see the board clearly will appear not to be paying attention. Vision screen should be confirmed before ADHD referral — not assumed to be adequate from the school screen.Visual impairment identified → refer to optometrist; may explain academic difficulties. Normal vision → ADHD referral proceeds.YES — exclude before ADHD referral
Hearing test (school screen or formal)Hearing impairment — particularly unilateral or mild-moderate hearing loss — causes apparent inattention and failure to follow instructions. Glue ear (OME) at school age causes fluctuating hearing loss affecting language and attention. Must be excluded before ADHD diagnosis.Hearing impairment → formal audiology + ENT. Glue ear → treatment; reassess attention after. Normal → ADHD referral proceeds.YES — exclude before ADHD referral
Thyroid palpation and signsHyperthyroidism (rare in children but possible) causes hyperactivity, inattention, difficulty concentrating, and emotional lability — a close clinical mimic of ADHD. Goitre, tachycardia, tremor, heat intolerance alongside ADHD features should prompt TFTs.Goitre or signs of hyperthyroidism → TFTs; treat underlying thyroid disease; reassess ADHD features. Normal → ADHD referral proceeds.Context — if clinical signs present
Neurological examination (if seizures suspected)Absence seizures (petit mal) cause brief episodes of inattention, staring, and apparent "zoning out" that are frequently misdiagnosed as ADHD. If there is any history of staring spells, eye blinking automatisms, or unexplained brief loss of contact: paediatric neurology referral (EEG is specialist-arranged) before ADHD management.Absence features → paediatric neurology referral; do NOT start stimulants before epilepsy excluded. Normal neurology → ADHD management pathway.YES — if staring spells or absence features present
🎓 SCA Checkpoint — Step 3Tasks
Examination rationale
"I am going to check Charlie's blood pressure, heart rate, height, and weight today — these are the baseline measurements we need before any medication is considered. I also want to make sure his vision and hearing are not contributing to the difficulties."
Deductions
  • Not recording baseline BP, HR, height, weight before any mention of medication
  • Not checking vision and hearing before ADHD referral
  • Missing absence epilepsy by not asking about staring spells
4
Step 4
Do I Need This Investigation?
▲collapse
ADHD has no diagnostic blood test or imaging. Investigations target differential diagnoses and pre-treatment safety baselines. Validated rating scales completed by parents and teachers are helpful adjuncts — not diagnostic tests — and referral should not wait for them.
InvestigationWhen indicatedWhat result changes management
Teacher rating scales (Conners 3, SNAP-IV, or NICHQ Vanderbilt) — arranged by GP before referralHelpful adjunct where feasible — DSM-5 requires symptoms in ≥2 settings and teacher scales provide school-setting data, but they are not NICE-mandated and cannot establish or exclude ADHD. Do not delay referral solely because a school questionnaire is unavailable. GP should provide the scale to the parent to take to school, or send directly to the SENCO.Elevated teacher score in inattention and/or hyperactivity domains → supports ADHD diagnosis; strengthens referral. Low teacher score → reconsider diagnosis; consider home-specific factors, anxiety, or learning disability as primary explanations for school difficulties.
TFTs (thyroid function tests) — if clinical features suggest hyperthyroidismNOT routine for ADHD. Indicated if: goitre, tachycardia, tremor, heat intolerance, or weight loss alongside ADHD features. Hypothyroidism: causes cognitive slowing and fatigue — less likely to mimic ADHD but possible. Congenital hypothyroidism causes neurodevelopmental delay.Hyperthyroidism → treat thyroid; reassess ADHD features after normalisation — some may resolve. Normal TFTs → ADHD assessment proceeds. Hypothyroidism → treat; monitor neurodevelopment.
FBC (full blood count) — if fatigue, pallor, or anaemia suspectedIron deficiency anaemia causes cognitive slowing, inattention, and fatigue that may be misattributed to ADHD. Particularly relevant in restricted-diet children (common in ADHD). NOT routine — only if clinical features suggest anaemia.Anaemia → treat iron deficiency; reassess ADHD features. Ferritin low with normal Hb (iron depletion without anaemia): consider iron supplementation — modest evidence that low ferritin worsens ADHD symptoms independently of haemoglobin.
ECG / cardiology advice — only if cardiac red flagsDo not request a routine ECG. Take a cardiovascular history and examination (including BP and pulse); refer for cardiology advice before medication if NICE cardiac red flags are present: congenital heart disease or previous cardiac surgery, sudden death in a first-degree relative under 40 suggesting cardiac disease, exertional breathlessness, exertional or fright/noise-induced syncope, sudden-onset rapid regular palpitations, cardiac chest pain, signs of heart failure or a murmur, or hypertension.Prolonged QTc (>450ms) → cardiologist review before stimulant; consider atomoxetine (lower cardiac risk). Structural heart disease → cardiology before any ADHD medication. Normal ECG in high-risk patient → stimulant can be considered; continue monitoring.
Lead level — if pica or environmental lead exposureLead neurotoxicity causes inattention, impulsivity, and cognitive impairment closely mimicking ADHD. Relevant in children with pica behaviour, those living in pre-1970s houses with lead paint, or those from countries with higher environmental lead exposure.Elevated lead level → remove from source; health protection notification; chelation if severe; neurodevelopmental support. Normal → lead toxicity excluded.
Adult ADHD screen (ASRS-v1.1) — for parent if FH or self-recognised features50% heritability — if Charlie has ADHD, there is a significant probability that at least one parent has it. Parental ADHD affects their ability to implement behavioural strategies consistently. Adult ADHD screen at the same appointment is both diagnostically appropriate and practically significant for management.Elevated ASRS score → adult ADHD assessment referral; impact on parenting capacity and employment acknowledged; parent may need their own medication and workplace adjustments. Normal ASRS → parental ADHD less likely; other explanation for parenting stress.
🎓 SCA Checkpoint — Step 4Tasks
Investigation rationale
"I am not ordering specific blood tests today — ADHD doesn't have a blood test. What I am doing is asking the school to complete a rating scale, which is the most important piece of information the specialist needs alongside your account."
Deductions
  • Not requesting school information (e.g. teacher rating scales) alongside the referral
  • Ordering a brain scan "to look for ADHD" — ADHD has no diagnostic imaging
  • Not seeking cardiology advice when NICE cardiac red flags are present
5
Step 5
Reaching a Diagnosis & DDx — Explained in Plain Language
▲collapse
ADHD is a clinical diagnosis made by a specialist — GP does not confirm it but describes the clinical picture accurately and refers promptly. The lay explanation of ADHD is one of the most therapeutically important components of the consultation — it corrects myths, reduces shame, and builds the therapeutic alliance needed for treatment engagement.
🗣️ Explaining ADHD in Plain Language

"Think of the brain's attention system like a car engine. In most people, the engine regulates its own speed — speeding up for interesting tasks and slowing down for routine ones. In ADHD, the engine's speed regulation is different — it doesn't stay in the optimal range as reliably without extra support. This is not about intelligence — Charlie's engine is clearly powerful. It is about the brain's ability to sustain its own attention without strong external fuel, like novelty, urgency, passion, or structure. This is why he can focus for hours on something he loves — his brain gets enough internal fuel. But for routine homework or sitting in a classroom lesson, there is not enough internal signal to keep the engine running at full speed. The medication we use for ADHD gives the brain's regulation system a small boost — it doesn't change the engine, it makes the speed regulation work better."

💬 Addressing the medication concern directly

"I don't want Charlie to become a zombie — flat and personality-less on medication."
"That description — the 'zombie effect' — is actually a sign that the dose is too high, not that the medication is wrong. At the right dose, methylphenidate works like glasses for someone with short-sightedness: it helps the brain do what it was always capable of, more reliably. The most common experience parents describe is 'he is finally himself — the version of himself he has been trying to be all along.' When you hear about children becoming flat and withdrawn on medication, that is almost always a dose that needs adjusting, not a reason to avoid treatment entirely."

A — ADHD (Specialist Diagnosis)
Specialist MDT diagnosis
ADHD-C (Combined): ≥6 inattentive + ≥6 hyperactive-impulsive symptoms; most common in children; most disruptive presentation
ADHD-I (Inattentive): ≥6 inattentive symptoms only; predominates in girls; less visible; diagnosed later; associated with anxiety and academic underachievement
ADHD-HI (Hyperactive-Impulsive): ≥6 hyperactive-impulsive symptoms only; less common; often younger children; evolves to combined or inattentive with age
B — Important Differential Diagnoses
Exclude before ADHD management

Absence Epilepsy

Staring spells, eye blinking, brief loss of contact — mimics inattention. EEG diagnostic. Urgent referral.

Anxiety Disorder

Inattention, restlessness, inability to concentrate — from worry, not executive dysfunction. CBT first; treat ADHD and anxiety as separate if both present.

Learning Disability / Dyslexia

Academic failure from specific learning difficulty, not ADHD. Educational psychology assessment; distinct management pathway.

C — Do Not Miss
Act urgently if present

ACEs / Trauma

Hypervigilance, impulsivity, emotional dysregulation from adverse childhood experiences mimics ADHD. Trauma-informed assessment required. CAMHS urgently.

Bipolar Disorder

Elevated mood, grandiosity, reduced sleep in episodes alongside ADHD features. Stimulants can precipitate mania. CAMHS before any medication.

📊 NICE NG87 Treatment Pathway by Age and Severity
Age / SeverityFirst-lineIf insufficientMedication notes
Under 5 yearsADHD-specific parent training programme ONLY — medication not recommendedSpecialist paediatric assessment; medication only in exceptional circumstancesMethylphenidate not licensed under 6 years. NICE NG87: no ADHD medication under 5 without a second specialist opinion from an ADHD service with expertise in young children.
5–18 years: mild-moderateADHD-specific parenting programme + school support (SENCO, SEND Support Plan)Medication if parenting programme insufficient and functional impairment persistsMethylphenidate first-line (Schedule 2); specialist titrates; GP shared care.
5–18 years: severe / significant impairmentSupport and environmental modifications, reviewed; medication if significant impairment persistsLisdexamfetamine if methylphenidate inadequate; atomoxetine if stimulant CISpecialist-initiated after assessment; expedite referral where risk is high (exclusion, safety).
Adults (18+)Lisdexamfetamine or methylphenidate first-line per NICE NG87Switch to the other after an adequate 6-week trial; atomoxetine if stimulant CIShared Care Agreement with GP. Workplace adjustments under Equality Act.
🎓 SCA Checkpoint — Step 5TasksRelating to Others
Explaining the ADHD pattern
"Based on what you have described — the difficulties in both school and at home for many months, across both the attention and the hyperactivity domains — I think a formal ADHD assessment is the right next step. I am not making the diagnosis today; that requires a specialist team. What I can say is that what you are describing fits the pattern we would want assessed."
Deductions
  • Diagnosing ADHD in the GP consultation — specialist assessment required
  • Not addressing the medication concern with specific, accurate information
  • Not explaining the non-medication pathway (support and environmental modifications before medication)
6
Step 6
If Referral Is Needed — What the GP Does Before & During
▲collapse
The quality of the GP referral determines the efficiency of the specialist assessment. A referral that includes parent and (where available) teacher information, baseline clinical measurements, a clear description of functional impairment in two settings, and the relevant differential diagnoses excluded allows the specialist to complete their assessment in far fewer appointments. A referral without these elements wastes months.
ReferralUrgencyWhat to includeWhat NOT to do
CAMHS / Community Paediatrics — ADHD assessmentRoutineParent history of symptoms in both settings; duration ≥6 months; onset before 12; both inattentive and hyperactive-impulsive features; functional impairment documented; teacher Conners/SNAP-IV attached if available; baseline BP/HR/height/weight; comorbidities (autism, anxiety, tics); family history ADHD; vision/hearing checked; differential diagnoses considered.Do NOT delay the referral solely because a school questionnaire is unavailable — send it now and forward school information when it arrives. Do NOT initiate methylphenidate in primary care without specialist assessment and diagnosis.
SENCO — school engagement and SEND Support PlanImmediateAdvise parents to contact SENCO immediately. SEND Support Plan can begin before diagnosis under the Equality Act and SEND Code of Practice. Teacher Conners/SNAP-IV rating scale to be completed and sent to GP. School observations are valuable supporting information for the assessment.Do NOT tell parents to wait for the ADHD diagnosis before approaching school. SEND support can and should begin now. Schools have statutory obligations regardless of diagnosis.
Urgent CAMHS — ADHD + conduct disorder + exclusion riskUrgent — 2 weeksDocument: school exclusion history; conduct disorder features; safeguarding concerns; family context. GP advocacy letter to school (behaviours reflect a medical condition under assessment). Request CAMHS consider urgency given exclusion risk.Do NOT allow school exclusion to proceed without GP advocacy. This is a medico-social emergency for this child's developmental trajectory.
Paediatric neurology — if seizures or absence spells suspectedUrgentDescription of staring episodes (duration, frequency, triggers, eye movements, post-ictal features). EEG is arranged by the specialist. Withhold all ADHD medication pending neurological clearance.Do NOT start stimulants if absence epilepsy is suspected — stimulants may lower seizure threshold. Neurology assessment first.
Adult ADHD pathway — for parent with suspected ADHDRoutineASRS-v1.1 score; occupational history; childhood school difficulties; family history; impact on parenting and employment. Adult ADHD is a recognised disability — Equality Act workplace adjustments applicable.Do NOT dismiss parental self-recognition as "identification with the child." Parental ADHD is clinically significant and has major implications for treatment engagement and family function.
🎓 SCA Checkpoint — Step 6Tasks
Referral plan
"I am going to write the referral today with all the clinical information, and I would like you to ask Charlie's teacher to complete a rating scale — I will print one for you to take in, or I can send it directly to the school. I am also advising you to speak to the SENCO this week about putting some additional support in place now, before the appointment comes through."
Deductions
  • Not requesting school information alongside the referral
  • Not advising immediate SENCO contact for school support
  • Initiating methylphenidate in primary care — specialist assessment required first
7
Step 7
Management — Expectations · Goals · Non-Medication · Drug Selector · Drug Cards · Psychosocial · Follow-Up · Safety-Netting
▲collapse
7A — Address the medication fear and the "wait and see" vs "do something now" tension
🤝
The most important thing to do today is not to prescribe — it is to correct the myths that will prevent the parent from accepting treatment when it is recommended
1
Validate — the worry is understandable

The medication fear is driven by real experiences (some children are over-dosed and do become flat) and significant online misinformation. Validating the concern before addressing it establishes trust and opens the parent to new information rather than triggering defensiveness.

"Your concern about medication is completely understandable — it is one of the most common things parents worry about, and it comes from a real phenomenon. I want to explain what it actually means and why it doesn't apply to medication at the right dose."
2
Explain — the zombie effect is over-dosing

The "zombie effect" (flat affect, reduced personality, robotic behaviour) is a dose-dependent side effect of over-dosing, not of methylphenidate per se. At the appropriate therapeutic dose, methylphenidate helps the child be more fully themselves. The correct clinical response to zombie-like behaviour is dose reduction, not drug cessation.

"The flat, zombie-like effect that you have read about is actually a sign that the dose is too high. At the right dose, most parents describe their child becoming more themselves — able to finish a thought, engage with a conversation, feel proud of something they completed. The medication doesn't change who Charlie is; it helps his brain do what it was always trying to do."
3
Plan — what happens today and what comes next

Today: referral made; teacher scales requested; SENCO advised; parental PHQ-9; ASRS for parent if appropriate; baseline measurements documented. Medication is not prescribed today — it is specialist-initiated. The plan is non-medication interventions while awaiting assessment. The waiting period is active, not passive.

"Medication won't be the first step — the specialist will assess Charlie, confirm the diagnosis, and then discuss options including non-medication approaches first. What we can do right now is get the school on board and make sure the referral is as strong as possible."
Key principle: NICE NG87 does not recommend medication as the automatic first step for mild-moderate ADHD in children. Parent training and school support come first. However, untreated ADHD causes cumulative harm — academic failure, self-esteem damage, peer rejection, family stress — that medication could prevent. The question is not "medication vs no medication" but "what is the right sequence of interventions for this child's level of impairment?"
7B — Treatment goals
Treatment goals
CAMHS/paediatrics referral made with teacher scalesSENCO engaged; SEND Support Plan initiated Parent training programme started (if mild-moderate)Baseline BP, HR, height, weight documented Parental guilt addressed with neurodevelopmental framingMedication fear corrected with accurate information Parental ASRS screen; adult ADHD referral if elevatedFollow-up in 6–8 weeks: referral progress + family wellbeing
Motivational language
"Untreated ADHD in childhood is associated with school failure, lower self-esteem, social isolation, and significantly higher rates of substance misuse in adolescence. Treated ADHD — whether with parent training, school support, medication, or all three — dramatically changes that trajectory."
"Charlie's intelligence and creativity are not in question — the difficulty has been his brain's access to them in low-stimulus situations. The right support gives him consistent access to what he already has."
7C — Non-medication management: the NICE NG87 foundation
NICE NG87 is explicit: for children aged 5–18, ADHD-focused support and environmental modifications (including at school) come before medication, and group parent training is first-line under 5. These interventions reduce the symptom burden, improve family relationships, and may reduce the medication dose needed. For severe ADHD, they should be initiated alongside medication, not instead of it.
👪
ADHD-Specific Parent Training
Group-based, ADHD-focused (NICE NG87)
Evidence

NICE NG87: ADHD-focused group parent training is first-line under 5; for ages 5–18 give ADHD-focused information and support (including group parent training, especially where there are symptoms of oppositional defiant or conduct disorder), with medication offered only if significant impairment persists after environmental modifications. Evidence base: New Forest Parenting Programme (NFPP), Incredible Years, Triple P.

Practical

Referral via CAMHS or Sure Start/Children's Centre. Teaches: clear and consistent routines; positive attention strategies; reducing negative interactions; understanding the neurodevelopmental basis of behaviour. Not generic parenting advice — ADHD-specific.

RCT evidence: NFPP reduces ADHD symptoms in 3–11-year-olds
🏫
School Support and Reasonable Adjustments
SEND Code of Practice; Equality Act 2010
Evidence

Schools are legally required to make reasonable adjustments for children with ADHD (Equality Act 2010 — ADHD is a disability if it substantially affects daily function). Common adjustments: preferential seating (front of class, near teacher); shorter task chunks; movement breaks; visual timers; homework adjustments; exam accommodations (extra time, separate room).

Practical

SENCO involvement from the outset. SEND Support Plan (can be initiated without diagnosis). EHCP application for significant impairment. GP supporting letter strengthens EHCP case. Academic accommodation (extra time in exams) requires evidence of diagnosis.

School adjustments can halve the gap between ADHD potential and performance
🧠
Psychoeducation for Child and Family
ADHD UK; CHADD equivalent; ADDISS
Evidence

Psychoeducation is a first-line component of ADHD management for all ages. Understanding the neurobiology of ADHD reduces shame, increases treatment adherence, and enables the child and family to be active partners in management rather than passive recipients of a diagnosis.

Practical

ADHD UK (adhduk.org). ADDISS (addiss.co.uk). "The ADHD Advantage" and similar books for parents. Age-appropriate explanation for Charlie himself — children who understand their ADHD diagnosis have significantly better self-advocacy and self-management than those who are not told.

Psychoeducation is evidence-based: reduces shame; improves adherence
😴
Sleep Hygiene and Sleep Disorders
Consistent routine; melatonin if refractory
Evidence

Sleep disorders are extremely common in ADHD — both primary (circadian rhythm dysregulation) and medication-related (stimulants delay sleep onset if taken too late). Poor sleep amplifies all ADHD symptoms. Treating the sleep disorder can significantly improve ADHD symptom control without dose escalation.

Practical

ADHD sleep hygiene: consistent bedtime; screen-free 1h before bed; physical activity during the day; methylphenidate dose timing (avoid after 4pm). Melatonin (off-label for non-autism sleep disorders in children) can be used after behavioural programme; arrange with specialist.

Treating sleep disorder often reduces medication dose needed
🏃
Physical Exercise
30 min aerobic exercise daily
Evidence

Aerobic exercise has the most consistent evidence base of any non-pharmacological ADHD intervention — comparable in effect size to low-dose methylphenidate for mild-moderate symptoms. Mechanism: exercise increases dopamine and noradrenaline release — the same neurotransmitters targeted by stimulant medication.

Practical

30 min brisk aerobic activity before school has the strongest evidence. Team sports, swimming, martial arts — activities with structure AND movement. Exercise is not a substitute for medication in moderate-severe ADHD but is an important adjunct for all ADHD presentations.

Dopamine + noradrenaline release mimics low-dose stimulant effect
📋
Structure, Routine, and Environment
External scaffolding; visual systems
Evidence

ADHD impairs the internal executive function system that creates, maintains, and follows structure. External scaffolding — visual schedules, checklists, timers, designated equipment locations, predictable routines — compensates for the internal executive function deficit and dramatically reduces ADHD-related chaos at home and school.

Practical

Visual daily schedule posted at eye level. Homework station with no other objects. Kitchen timer for task chunks (Pomodoro). Colour-coded timetable. Equipment checklist at the door. These are not "babyish" for a 9-year-old — they are neurologically appropriate accommodations for a brain that processes time and sequences differently.

External structure halves homework and morning-routine conflicts
7D — Prescribing guide: NICE NG87 stepped approach
ADHD medication is specialist-initiated — GP does not start methylphenidate or lisdexamfetamine without a specialist diagnosis and recommendation. However, GP prescribes on Shared Care Agreement after specialist titration. Monthly Schedule 2 CD prescriptions (methylphenidate, lisdexamfetamine): prescription valid for 28 days and quantity not normally more than 30 days' treatment; follow the local shared-care protocol and practice CD policy; no telephone prescription requests.
First-line: Methylphenidate (Children 5–18)

Concerta XL 18–54mg OD or Ritalin LA 10–40mg OD — modified-release preferred for once-daily dosing

  • Schedule 2 CD — specialist initiates; GP prescribes on shared care after titration
  • Modified-release (XL/LA): covers school hours; reduces rebound; once-daily; preferred over immediate-release for convenience and adherence
  • Immediate-release: used for flexible dosing, top-up doses, or when MR not tolerated
  • NICE NG87: if methylphenidate inadequate after 6 weeks at optimised dose — switch to lisdexamfetamine
CD prescription valid 28 days; quantity not normally over 30 days' treatment. Specialist titrates; GP maintains on shared care. Never initiate in primary care without specialist diagnosis.
Second-line Children / First-line Adults (with methylphenidate): Lisdexamfetamine (Elvanse)

Elvanse 20–70mg OD — NICE NG87 first-line option for adults (alongside methylphenidate); children if methylphenidate insufficient

  • Pro-drug of dexamfetamine (must be metabolised to be active) — the specialist may prefer it where misuse or diversion is a concern
  • Longer duration of action (12–14 hours) — better coverage of after-school and homework hours
  • NICE NG87: first-line option for adults (lisdexamfetamine or methylphenidate); second-line for children after inadequate methylphenidate response
Non-Stimulant Alternatives: Atomoxetine / Guanfacine

Atomoxetine (Strattera): ADHD + anxiety, tics, or substance misuse risk

  • Atomoxetine: NE reuptake inhibitor; not a CD; takes 4–6 weeks for full effect; considered after inadequate response or intolerance to stimulants — comorbid anxiety, tics or substance misuse need individualised specialist choice
  • Guanfacine MR (Intuniv): alpha-2 agonist; not a CD; an option in NICE NG87 (age 5+); particularly useful for ADHD + tics or ADHD + oppositional behaviour; sedation common initially
  • Neither non-stimulant is a controlled drug — prescribed under shared care without CD regulations
7E — Medication options — guideline summary (no patient selection)
Situations this summary covers
  • Child aged 5–18
  • Adult (18+)
  • Significant anxiety or tics
  • Substance misuse risk
  • ODD / oppositional behaviour
  • Sleep disorder
Medication selection guide
Child 5–18: Methylphenidate MR (Concerta XL or Ritalin LA) first-line — specialist initiates; GP shared care. If inadequate: Lisdexamfetamine (Elvanse). Adult: Lisdexamfetamine or methylphenidate first-line (NICE NG87). Stimulants inadequate or not tolerated: Atomoxetine (Strattera) or, in children and young people, Guanfacine MR (Intuniv) on specialist advice. Anxiety/tics/substance misuse: individualised specialist choice with slower titration and closer monitoring — no option universally preferred. Sleep: ADHD sleep hygiene + evening timing of stimulant; melatonin if refractory. NEVER initiate methylphenidate or lisdexamfetamine in primary care without specialist diagnosis and recommendation.
Guideline summary — each situation is shown with what the guidance says for it, as written. Nothing is selected or worked out for an individual patient. Check doses in the SPC and your local formulary.
7F — Drug reference cards
Methylphenidate MR (Concerta XL / Ritalin LA)
Concerta XL 18/27/36/54mg OD · Ritalin LA 10/20/30/40mg OD · Schedule 2 CD
✓ First-line (children 5–18)
First-line children 5–18Start 18mg OD; titrate to 54mg max
✓ Prefer when
First-line for children and adolescents aged 5–18 with confirmed ADHD diagnosis from specialist
Modified-release (XL/LA) preferred over immediate-release — once-daily dosing, covers school and homework hours, reduces end-of-dose rebound
Rapid onset (30–60 min); wears off by evening — minimal sleep disruption if taken before 8am
✗ Avoid if
MAOI within 14 days; phaeochromocytoma; hyperthyroidism; severe arrhythmia; structural heart disease; severe hypertension
Significant anxiety — may worsen; specialist advice, slower titration, closer monitoring. Tics — not a reason to withhold; specialist advice if tics significantly worsen. Substance misuse in household — safe storage discussion mandatory.
⚠ Side effects
Appetite suppression (breakfast before dose), sleep delay if too late, elevated BP and HR, headache, irritability on wearing off ("rebound"), abdominal pain. Growth: height 6-monthly, weight at NICE age intervals, on centile chart.
🔬 Monitor
BP and HR before and after dose changes and every 6 months. Height every 6 months; weight every 3 months if aged 10 or under (centile chart). Tics. Mood. Appetite diary. "Is the child still himself?" — reassess if flat affect. At least annual specialist review of ongoing need (a planned break may help, as a joint decision).
💬 Counselling

"Give this tablet first thing in the morning, before or with breakfast. The effect lasts through school and homework. Do not give after 4pm — it will affect sleep. The appetite effect means lunch may be lighter than usual — offer a good breakfast and a larger evening meal. Tell us if Charlie seems flat or unlike himself; that means the dose needs adjusting, not stopping."

Schedule 2 CD: prescription valid 28 days; quantity not normally over 30 days' treatment. Specialist initiates; GP maintains on shared care. The "zombie effect" is a dose-dependent effect — specialist dose review, do not simply stop. Growth monitoring at NICE intervals mandatory. At least annual specialist review of ongoing need.

Lisdexamfetamine (Elvanse)
Elvanse 20/30/40/50/60/70mg OD · Schedule 2 CD · First-line option in adults (NICE NG87)
✓ First-line option adults; second-line children
First-line adults / Second-line childrenStart 20–30mg OD; max 70mg OD
✓ Prefer when
Adults with ADHD — NICE NG87: lisdexamfetamine or methylphenidate first-line in adults
Children: methylphenidate inadequate after 6 weeks at optimised dose — switch to lisdexamfetamine
Pro-drug (must be metabolised to be active) — may be preferred by the specialist where misuse or diversion is a concern
Longer duration of action (12–14 hours) — better evening coverage for homework and after-school activities
✗ Avoid if
Same cardiac and MAOI contraindications as methylphenidate; also avoid if history of stimulant misuse (though lower risk than dexamfetamine itself)
⚠ Side effects
Appetite suppression (more pronounced than methylphenidate), weight loss, insomnia, elevated BP and HR, dry mouth, emotional lability, growth restriction in children. Monitor weight closely.
🔬 Monitor
BP and HR before and after dose changes and every 6 months. Height 6-monthly; weight at NICE age intervals (children). Annual reassessment. Adults: BP, HR, weight, occupational and relationship function.
💬 Counselling

"This tablet takes 1–2 hours to work and lasts up to 14 hours. Take it first thing in the morning. Appetite will likely be reduced during the day — eat a good breakfast before taking it, and a bigger meal in the evening. Tell us if you feel significantly different, flat, or if you are losing significant weight."

In ADULTS NICE NG87 offers lisdexamfetamine or methylphenidate first-line — in children methylphenidate is first-line and lisdexamfetamine second. This is a high-yield exam distinction. Pro-drug = may be preferred by the specialist where misuse or diversion is a concern. 12–14-hour duration = better coverage than methylphenidate for adults with evening demands.

Atomoxetine (Strattera) — Non-Stimulant
Strattera 10/18/25/40/60/80/100mg OD or BD · NOT a controlled drug
✓ Non-stimulant first-choice
Non-stimulant; stimulants failed or not tolerated0.5mg/kg/day → 1.2mg/kg/day; max 100mg
✓ Prefer when
Stimulants ineffective or not tolerated (children after inadequate stimulant response; adults if stimulants not tolerated or ineffective)
ADHD + comorbid anxiety, tics or substance misuse — an option after individualised specialist assessment; no option is universally preferred
Substance misuse risk — not a CD; cannot be misused/diverted in the same way as stimulants
Diversion concerns — not a CD, though choice remains individualised
✗ Avoid if
MAOI within 14 days; narrow-angle glaucoma; phaeochromocytoma; severe hepatic failure
Takes 4–6 weeks for full effect — patients often stop too early; warn family explicitly at initiation
⚠ Side effects
Nausea (give with food), reduced appetite, initial insomnia, BP increase, mood changes. Black-box warning: suicidal ideation in children and adolescents — monitor closely in first 12 weeks especially. Hepatotoxicity (rare but warn: jaundice, dark urine → stop immediately).
🔬 Monitor
BP and HR. Growth (height, weight). Mood and suicidal ideation (black-box: monitor at 1, 2, 4, 8, 12 weeks after starting). LFTs only if clinically indicated (not routine). Takes 4–6 weeks — inform family at every review until full effect established.
💬 Counselling

"This medication is different from the other ADHD tablets — it is not a stimulant. It takes 4–6 weeks to build up to its full effect, so please don't judge it in the first week or two. Take it with food to reduce stomach upset. Please tell us immediately if Charlie's mood changes or if he says anything worrying."

Atomoxetine takes 4–6 weeks for full effect — warn family at initiation; this is the most common reason for early stopping. Black-box: suicidal ideation in children — monitoring schedule 1/2/4/8/12 weeks. NOT a controlled drug — prescribing regulations less restrictive than methylphenidate. Used after stimulant failure or intolerance; comorbidity-driven choices are individualised by the specialist.

Guanfacine MR (Intuniv) — Non-Stimulant
Intuniv 1/2/3/4mg OD · NOT a controlled drug · in NICE NG87 for ADHD (age 5+)
✓ ADHD + tics / ODD
Tics/ODD/oppositional; NICE NG87 option1mg OD; titrate weekly; max 4mg OD
✓ Prefer when
ADHD + tic disorder — a specialist option in children and young people if tics worsen significantly on stimulants (NG87 does not routinely withhold stimulants for tics)
ADHD + oppositional defiant disorder (ODD) — guanfacine reduces emotional dysregulation, irritability, and oppositional behaviour better than stimulants alone
Stimulant not tolerated or not effective — children and young people, on specialist advice; not initiated in adults without tertiary ADHD service advice
✗ Avoid if
Bradycardia; significant hypotension; renal failure
Sedation is common initially — warn family; avoid activities requiring full alertness until stable. Do NOT stop abruptly — taper to avoid rebound hypertension (rare but reported).
⚠ Side effects
Sedation (most common; usually improves over 2–4 weeks), hypotension, bradycardia, dizziness, nausea, dry mouth. QTc prolongation at higher doses — ECG if cardiac concerns.
🔬 Monitor
BP and HR at baseline and after each dose increment. Weekly BP monitoring during titration. ECG if cardiac concerns. Sedation: typically improves after 2–4 weeks; persistent sedation → reduce dose.
💬 Counselling

"This tablet works differently from the stimulant ADHD medications — it helps with the emotional regulation and impulsivity as well as attention. It often makes children feel a bit sleepy at first, which should settle. Give it in the evening initially to reduce daytime sedation. Do not stop it suddenly — we will reduce it gradually when the time comes."

Guanfacine MR (Intuniv) is an option for ADHD in NICE NG87 (children 5+ and young people) and is a specialist option after inadequate response or intolerance to stimulants; not for adults without tertiary advice. Not a controlled drug. The sedation side effect is common initially — warn family. Never stop abruptly (rebound hypertension risk). Useful when stimulants are contraindicated or ineffective.

Dexamfetamine — Third-Line / Specialist Use
Dexamfetamine 5mg tablets · Schedule 2 CD · Specialist-initiated; rarely first-line
✓ Third-line / specialist
Third-line; specialist; Schedule 2Start 2.5–5mg OD; titrate cautiously
✓ When considered
Methylphenidate AND lisdexamfetamine have failed or are not tolerated — dexamfetamine may be tried as a third-line specialist option
Sometimes used in adults with complex ADHD when flexible immediate-release dosing is required
Schedule 2 CD with higher misuse potential than lisdexamfetamine — prescribe with caution; monthly prescriptions; safe storage mandatory
✗ Cautions
Same contraindications as methylphenidate + lisdexamfetamine
Higher misuse potential than lisdexamfetamine; avoid in substance misuse settings. Rarely used as first-line in any age group in UK.
⚠ Side effects
Appetite suppression, weight loss, insomnia, cardiovascular effects as per methylphenidate/lisdexamfetamine. Higher stimulant potency — monitor BP carefully.
🔬 Monitor
BP and HR at every review. Growth monitoring. Annual reassessment. Restricted to specialist initiation only. Monthly CD prescriptions.
💬 Counselling

"This is a more potent stimulant medication that has been recommended by the specialist after other options were tried. The monitoring requirements are the same. Tell us immediately if you notice significant mood changes, very rapid heartbeat, or if you are concerned about the medication."

Dexamfetamine is third-line and specialist-initiated in the UK. Rarely encountered in a primary care SCA scenario. If seen: it is a Schedule 2 CD; higher misuse potential than lisdexamfetamine; monthly prescriptions; specialist oversight required throughout.

Melatonin — Sleep Disorder in ADHD
Adaflex (licensed 6–17 with ADHD) · Slenyto (autism-specific) · Circadin (licensed adults 55+ only)
✓ ADHD sleep comorbidity
Sleep comorbidity; after hygiene programme2–5mg ON; 30–60 min before bed
✓ When appropriate
ADHD-associated insomnia — circadian rhythm dysregulation causes delayed sleep phase in many ADHD children; melatonin helps advance sleep onset
Stimulant-related sleep delay — if methylphenidate is taken too late, melatonin helps re-establish sleep onset; consider moving stimulant dose earlier first
Adaflex (immediate-release melatonin) is licensed for insomnia in children aged 6–17 with ADHD when sleep hygiene has not been enough; Circadin is licensed only for adults aged 55+ (SPC)
✗ Cautions
Evaluate whether the sleep problem is stimulant-related (timing adjustment of methylphenidate may resolve it before adding melatonin)
Behavioural sleep programme mandatory first — melatonin as adjunct not replacement for sleep hygiene
⚠ Side effects
Generally well tolerated. Daytime drowsiness (reduce dose). Headache. Enuresis (rare). Annual review of continued need.
🔬 Monitor
Sleep diary at 2 and 6 weeks. Check stimulant timing — is sleep problem medication-related? Annual cessation trial. If no response at 2mg: increase to 5mg.
💬 Counselling

"Give this 30 minutes before the bedtime routine ends. It works best alongside a consistent routine — devices off, same bedtime every night. Keep the room dark. It should help Charlie's brain recognise that it is time to sleep."

ADHD sleep disorder is an important comorbidity. Check stimulant timing first (late-dose methylphenidate delays sleep). Adaflex is the melatonin licensed for children 6–17 with ADHD (Circadin is licensed only for adults 55+). Annual review. Sleep improvement significantly reduces ADHD symptom burden during the day.

7G — Psychosocial impact: shame, identity, and the family system
🤝
ADHD — not a behaviour problem, a brain difference that changes everything
The psychosocial impact of undiagnosed ADHD accumulates over years. By age 9, Charlie has experienced thousands of instances of being told he is not trying hard enough, is naughty, is disruptive, is lazy. This accumulated shame shapes his emerging identity in ways that persist regardless of whether medication later improves his attention. The diagnosis is not just a label — it is a rewriting of every failed attempt as a symptom of a medical condition, not a moral failing.
😔
Shame and Identity

Years of "you could try harder" have convinced Charlie at some level that he is not as capable as others, is defective, is difficult. This shame is the most persistent consequence of undiagnosed ADHD — it outlasts the academic failure and the school problems.

The diagnosis, delivered clearly and non-pathologically, allows reframing: "everything that went wrong was not your character — it was your neurology."

"How does Charlie feel about school? Does he feel like he is trying his best but it is not enough? Because if he does — and that feeling is very common in children with ADHD — that is something I really want to address when we talk to him."
👨‍👩‍👦
Family Relationships

ADHD creates enormous family stress — homework battles every evening, explosive arguments, constant lost items, school complaints. Siblings receive less parental attention. The family adapts its entire life around managing the ADHD behaviour without knowing that is what they are doing.

The diagnosis often produces relief in families — not alarm. "We finally have a name for it" is the most common response. This relief should be validated.

"How has this been affecting your family life — the homework battles, the daily routine? And how are the other children at home managing through all of this?"
🏫
School Relationships and Exclusion Risk

ADHD children are 3× more likely to be excluded from school. Teacher-student relationships are often damaged — teachers who have interpreted ADHD behaviour as wilful defiance have disciplined and distanced themselves from the child. The diagnosis changes the teacher's attribution and ideally changes the relationship.

GP advocacy to school is important: "this behaviour is a manifestation of a medical condition that is being assessed and will receive treatment."

"Is Charlie's relationship with his teacher a positive one? Has he been in trouble at school, and if so — has that affected how he feels about going in every day?"
👫
Peer Relationships

ADHD impairs social function through impulsivity (interrupting, invading personal space), emotional dysregulation (explosive reactions), and poor turn-taking. Children with ADHD are rejected by peers faster than any other diagnostic group — within minutes of meeting a new child, ADHD behaviour triggers social rejection.

Social skills groups, structured activity clubs (sports teams, coding clubs, drama) provide scaffolded social environments where ADHD behaviour is less impairing.

"Does Charlie have friends — does he find friendships easy or difficult? Sometimes the impulsivity that comes with ADHD can make friendships harder than they would otherwise be."
💼
Parental Employment and Wellbeing

Parents of ADHD children report significantly higher work disruption, relationship stress, and personal anxiety than matched controls. The parent with undiagnosed ADHD has additional occupational difficulties of their own. PHQ-9 at every ADHD consultation. Adult ADHD screen (ASRS-v1.1) for both parents.

"How are you both doing personally — your mood, your work? Parenting a child with ADHD is genuinely exhausting, and your own wellbeing matters just as much as Charlie's."
🔮
Prognosis and the ADHD Advantage

60% of childhood ADHD persists into adulthood. Many adults with ADHD describe their condition as a source of creativity, energy, hyperfocus, and entrepreneurialism when properly managed and channelled. The worst outcomes of ADHD (substance misuse, criminal justice, employment failure, relationship breakdown) are largely preventable with early diagnosis and treatment. The best outcomes are remarkable.

"I want to end with something important: with the right support, children with ADHD go on to achieve extraordinary things. Some of the most creative, entrepreneurial, and driven adults describe ADHD as part of what makes them exceptional. The diagnosis is not a ceiling — it is a starting point for getting Charlie the support that will allow him to flourish."
7H — Follow-up schedule
1
6–8 Weeks — Referral Progress + School + Family

Referral acknowledged? Teacher Conners scale completed and forwarded (if not already sent)? SENCO engaged? Parent training programme arranged? Sleep: any improvement with hygiene programme? Parental PHQ-9. ASRS result reviewed (parent ADHD screen). Baseline measurements confirmed in notes. Any escalation (school exclusion risk)?

Referral progress; teacher scaleParental PHQ-9; ASRS
2
Post-Diagnosis — Shared Care Initiation

Diagnosis confirmed? Shared Care Agreement received from specialist? Methylphenidate (or lisdexamfetamine for adults) initiated by specialist. First GP prescription: confirm shared-care agreement details; CD quantity not normally over 30 days' treatment. Baseline BP/HR/height/weight confirmed. Medication counselling given. Parent ADHD assessment arranged if indicated.

Shared Care AgreementCD Rx: ≤30 days' treatment
3
4–6 Weeks Post-Initiation — First Medication Review

BP and HR (check against baseline). Weight (check against centile). Appetite: significant suppression? Growth trajectory. Mood: flat affect ("zombie")? → reduce dose. Tics: new or worsened? Sleep: stimulant-related delay? → move dose earlier. Academic and behavioural response: teacher and parent report. Dose adjustment referral to specialist if needed.

Zombie effect: reduce dose not stopGrowth: centile chart
4
6-Monthly — Ongoing Monitoring Review

Height centile every 6 months; weight every 3 months if aged 10 or under (NG87). BP and HR. Mood and behaviour. Academic performance and school adjustment. Medication still needed? At least annual specialist review — a planned break can help judge ongoing need, as a joint decision. Parental wellbeing. Transition planning from child to adult services from age 16.

Height 6-monthly; weight per NICE age intervalsAnnual specialist review
5
Transition to Adult Services (Age 16–18)

ADHD persists in 60% of childhood cases. Transition planning begins at 16: adult ADHD services referral; Shared Care Agreement update; driving licence considerations (DVLA: tell DVLA if ADHD or its medication affects the ability to drive safely); employment support; Equality Act workplace adjustments.

DVLA if ADHD or medication affects drivingAdult ADHD services referral
7I — Monitoring: the ADHD minimum dataset

Every 6-monthly ADHD review — mandatory minimum dataset

At every review: BP and HR (stimulant cardiovascular effects); height and weight centile chart (growth restriction — mandatory; cannot be omitted); appetite and weight loss (significant loss → dietary support or dose holiday); mood and personality (flat affect = over-dosing; reduce dose, do not stop); tics (new or significantly worsened = specialist advice); sleep (stimulant timing; melatonin if needed); academic and behavioural function (is medication still needed?); annual specialist review (is medication still needed? a planned break is a joint decision).

MedicationMonitorTimingAction threshold
Methylphenidate (all formulations)BP, HR, height, weight centile, mood, tics, appetite4–6 weeks post-start; then 6 monthlyBP >95th centile → reduce dose; specialist review. Growth faltering → drug holiday; dietitian. Flat affect → dose reduction. New tics → specialist advice.
Lisdexamfetamine (Elvanse)BP, HR, height, weight, mood, appetite (appetite suppression more pronounced)4–6 weeks post-start; then 6 monthlySignificant weight loss → dose holiday; dietary support. Mood elevation → bipolar screen; specialist. Same cardiovascular monitoring as methylphenidate.
Atomoxetine (Strattera)BP, HR, height, weight, mood (black-box suicidal ideation), LFTs if symptoms1, 2, 4, 8, 12 weeks post-start; then 6 monthlySuicidal ideation → stop; CAMHS same day. Jaundice/dark urine → stop immediately; LFTs; hepatology. Takes 4–6 weeks — do not judge efficacy before 6 weeks.
Guanfacine MR (Intuniv)BP, HR (bradycardia risk during titration), sedation, weightWeekly during titration; then 6 monthlyBradycardia (HR <55) → reduce dose; specialist review. Persistent sedation >4 weeks → reduce dose. Never stop abruptly — taper over weeks.
ScenarioActionPrinciple
Flat affect / zombie effect on methylphenidateSpecialist dose review (no primary-care dose change without specialist instruction)The zombie effect is over-dosing. Reduce dose, do not stop. Do not switch drug class before dose optimisation.
New tics on methylphenidateMonitor; if significantly worsening → specialist advice (guanfacine is a specialist option)Evidence on stimulants and tics is mixed. Monitor closely; switch only if tics clearly worsen significantly.
Appetite suppression / growth falteringMove dose to after breakfast; add afternoon snack; drug holiday assessment; dietitianMorning breakfast before dose. Growth holiday (school holiday trial) provides reassurance and growth catch-up.
Annual drug holidayPlan during summer holiday; structured comparison; teacher and parent rating scales before and afterCan help judge whether medication is still needed, as a joint specialist–family decision. NICE NG87 makes no general recommendation for holiday breaks (planned break only if growth significantly affected).
School exclusion during assessment waitGP advocacy letter immediately; SENCO emergency contact; EHCP emergency reviewADHD is a disability under the Equality Act. Exclusion for ADHD behaviour may be unlawful. GP letter can be decisive.
7J — Safety-netting

⚠ Three scenario-specific safety-net phrases

🔴 Zombie effect on medication — reduce dose, do not stop
"If Charlie seems flat, unlike himself, or robotic on the medication — that is a signal that the dose is too high, not that medication is wrong for him. Please contact us within a week if this happens. The dose needs reducing, not stopping. If you stop it abruptly, the ADHD symptoms will return immediately and we will lose the progress made."
The most common reason parents stop ADHD medication is the over-dosing effect. They interpret it as "medication is wrong for my child" when the correct response is dose reduction. This safety-net pre-empts inappropriate medication cessation.
💊 Cardiovascular — return promptly for any symptoms
"If Charlie develops chest pain, a very fast or irregular heartbeat, or faints while on the medication — stop the medication and contact us the same day, not next week. These are symptoms we take seriously with this class of medication. They are uncommon but they need prompt attention."
Stimulants increase BP and HR. Arrhythmia and cardiac events are rare but serious adverse effects. Pre-warning parents to seek same-day review for cardiovascular symptoms is both clinically protective and medico-legally important.
🟠 Mood change or suicidal ideation (atomoxetine)
"With atomoxetine specifically, there is an important warning: in a small number of children, it can cause changes in mood, including very rarely thoughts of self-harm. If you ever notice Charlie expressing thoughts about hurting himself, or if his mood changes dramatically, stop the medication immediately and contact us or go to A&E. This is rare but it is important to know."
Atomoxetine black-box warning: suicidal ideation in children and adolescents. This must be communicated at initiation — not left in a patient information leaflet that may not be read. Document that the warning was given verbally.
6–8 WeeksReferral progress; teacher scales; SENCO; parent training; PHQ-9; ASRS
Post-medication start4–6-week review: BP, HR, weight centile, mood, tics, sleep, academic response
6 MonthlyGrowth centile (weight 3-monthly if ≤10); BP/HR; mood; tics; annual specialist review; transition planning from age 16
🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills
Closing the consultation
"ADHD is a neurodevelopmental condition — it is not caused by parenting, screens, or diet. There is nothing you could have done differently. Charlie has been trying his best the whole time."
"I am referring Charlie to the CAMHS team today. I would also like you to take this rating scale to his teacher — it takes about 10 minutes and helps the specialist, but the referral will not wait for it."
"On the medication question: medication will not be the first step. The specialist will assess and discuss options — including approaches without medication. If medication is recommended, the zombie effect you have read about is a sign the dose is too high, not a reason to avoid it entirely."
"I want to check how you are both doing — parenting a child with these difficulties is genuinely exhausting. I would also like to do a brief questionnaire about your own attention and concentration."
"Please contact the school SENCO this week — support does not need to wait for a diagnosis. Is there anything else before we finish?"
Deductions — closing
  • Not addressing parental guilt directly with neurodevelopmental framing
  • Not requesting school information alongside the referral
  • Not correcting the medication fear with specific information
  • Initiating methylphenidate without specialist diagnosis
  • Not advising SENCO contact before specialist appointment
  • Not offering parental ADHD screen (ASRS-v1.1)
Tasks — full criteria
  • Both DSM-5 domains confirmed; two settings documented
  • Referral made with teacher rating scales requested
  • Baseline BP, HR, height, weight documented
  • Parental guilt addressed with neurodevelopmental framing
  • No methylphenidate initiated in primary care without specialist
Relating to Others
  • Parental guilt named and corrected with empathy
  • Medication fear addressed accurately ("zombie = over-dosing")
  • Non-medication pathway explained (parent training first)
  • ICE all three explored and linked to plan
  • Parental ADHD screen offered; parental wellbeing named
  • SENCO advised; school support not deferred; closing question
🔴 Red
Parental guilt not addressed; teacher scales not requested; methylphenidate initiated in primary care; medication fear not corrected; school not mentioned; sugar/screen myth reinforced; single setting only
🟠 Amber
Two settings confirmed but teacher scales not requested; parental guilt acknowledged but not corrected; medication concern noted but addressed vaguely; non-medication pathway not explained; parental ASRS not offered
🟢 Green
Parental guilt corrected with neurodevelopmental framing; two settings + both domains; teacher scales requested; SENCO advised; medication concern addressed accurately; non-medication pathway explained; baseline measurements; parental ASRS offered; ICE all three; closing question
ADHD — SCA Consultation Scorecard
NICE NG87 · DSM-5 · RAG self-assessment · Two settings + teacher scales + medication fear addressed
0/ 33 pts
🌐
Global Skills
Structure, language, responsiveness
0/7
✓
Tasks
Clinical reasoning, referral, management
0/15
🤝
Relating to Others
Communication, rapport, shared decision making
0/11
RAG Self-Assessment
🔴 Red
Parental guilt not addressed; teacher scales not requested; methylphenidate initiated in primary care; medication fear not corrected; single setting only; absence epilepsy not screened; no ICE; sugar/screen myth reinforced
🟠 Amber
Two settings confirmed but teacher scales not requested; parental guilt acknowledged but not corrected; medication fear vaguely addressed; non-medication pathway not explained; parental ASRS not offered; SENCO not mentioned
🟢 Green
Parental guilt corrected; two settings + both domains; teacher scales requested; SENCO advised; zombie effect corrected accurately; non-medication pathway explained; baseline measurements; ASRS offered; absence epilepsy screened; ICE all three; closing question
011172533
Fail
Borderline
Pass
Strong pass
📋
Complete the checklist above to see your score interpretation
"I've brought Charlie in because his school have been concerned for a while, and they've asked us to get him referred. He's 9, he's clearly very bright — he knows everything about the Second World War — but he just cannot sit still in class, he's always in trouble for calling out, and he loses everything. Homework is a daily battle. I feel terrible because I've been thinking he was just being naughty, and now I'm wondering if there's been something going on all along."
Who you are

Sarah Jenkins (38, accountant — works full time; notices she struggles to concentrate on tasks herself and sometimes wonders if she might have ADHD). Dan Jenkins (40, self-employed builder). Charlie (9, Year 5). One younger sibling (Ella, 7). Charlie's paternal uncle has a formal ADHD diagnosis. The school SENCO has been involved for 6 months and has completed a Conners 3 teacher rating scale (score highly elevated in both inattentive and hyperactive-impulsive domains). Charlie is not excluded but has had several fixed-term exclusions in the past year for calling out and disrupting lessons. His reading is above average; his written work is chaotic.

Hidden agenda and concerns

Primary concern: Sarah has read online that children on methylphenidate become "zombie-like" — flat, personality-less, unable to feel. She watched a video of a child before and after medication who appeared dramatically different and diminished. She is genuinely frightened of this. She will not mention it unless asked about the medication — she expects to be pressured into medication and is bracing for this.

Secondary concern: Sarah feels profound guilt. She has punished Charlie repeatedly for "being naughty" — taking away screen time, shouting, giving him stern talks about trying harder. Looking back, she is beginning to wonder if she made things worse. She needs the GP to explicitly tell her she has not caused this and that Charlie was not being wilfully disobedient.

Third concern (not mentioned unless asked): Sarah struggles at work to complete administrative tasks, loses her train of thought in meetings, and was recently told by her manager she misses details. She wonders if she has ADHD herself. She will respond positively if the GP offers an adult ADHD screen.

Clinical details if asked
  • Duration: "He has always been like this — even at nursery they said he was a handful. This has been going on his whole life."
  • Settings: School (SENCO involved; Conners elevated) + home (homework battles, losing things, explosive arguments) — two settings confirmed
  • Inattentive: cannot finish homework; loses pencil case, PE kit, jacket weekly; misses parts of instructions; easily distracted; forgets dentist appointments; struggles in class unless one-to-one
  • Hyperactive-impulsive: cannot sit at dinner table for a full meal; calls out in class; acts without thinking (not malicious but impulsive); struggles to wait his turn in games
  • Sleep: falls asleep at 10–11pm; wakes naturally at 6:30am; 7–8 hours total. Not a major complaint.
  • No staring spells, no seizures, no fainting. No significant mood episodes. No tics. Vision and hearing checked at school — normal.
Reactions to key moments
  • When parental guilt is addressed: Visibly emotional — "I feel terrible about how many times I told him to just try harder." Then significant relief when told it is a neurodevelopmental condition.
  • When medication fear is surfaced and asked about: "I've seen videos online of children who look completely blank on Ritalin. I don't want Charlie to become like that." → Responds well to accurate, specific correction: zombie = overdosing; right dose = more himself.
  • When adult ADHD screen is offered: Hesitant surprise then interest — "I have been wondering about myself actually. I've always struggled but just thought everyone was like this."
  • Challenge line: "My husband thinks we should just try harder with routine and discipline before going down the medication route. Is that an option?"
"My husband Dan thinks we should try harder with a strict routine and discipline at home before we consider medication. He's worried about putting Charlie on pills. Can we try without medication first, or is that not possible?"

Resolution: Sarah will be fully satisfied and reassured if the candidate: (1) addresses parental guilt directly and emphatically ("this is neurodevelopmental; you did not cause it"); (2) explains the medication concern accurately ("zombie = overdosing, not medication itself; right dose = more himself"); (3) answers the challenge that trying without medication first is a valid option (NICE NG87 offers medication at 5+ only if symptoms still cause significant impairment after environmental modifications); (4) requests school information without delaying the referral; (5) advises SENCO contact immediately; (6) offers ASRS adult screen for Sarah; (7) leaves Sarah with a specific, achievable action plan. She will disengage if told "let's wait and see," if methylphenidate is initiated at this appointment, or if the medication fear is dismissed without being specifically addressed.

🏥
Clinic Quick Reference
ADHD — Clinical Decision Framework
NICE NG87 (2018, updated 2019) · DSM-5 · Two or more settings
▼expand
🚦 1 — Triage & Referral Algorithm
Suspected ADHD → confirm two settings → exclude absence epilepsy, anxiety, hearing/vision → refer (request teacher rating scales alongside)
↓
🔴 Urgent (<2 weeks)
  • ADHD + staring spells / absence episodes: paediatric neurology (EEG specialist-arranged) BEFORE any ADHD management
  • ADHD + significant mood episode (bipolar screen): CAMHS before medication
  • ADHD + conduct disorder + exclusion risk: CAMHS urgent + EHCP + social care
  • Safeguarding concern: children's social care + CAMHS
Absence epilepsy first: never start stimulants before neurology assessment if staring spells present
🟠 Expedited
  • School exclusion imminent: GP advocacy letter + SENCO emergency EHCP review
  • Parental ADHD suspected: adult ADHD assessment pathway (ASRS-v1.1)
  • Substance misuse: expedited CAMHS; individualised specialist drug choice
Exclusion: GP advocacy letter — ADHD behaviour may be unlawful to exclude
🟢 Routine
  • Two-setting ADHD: CAMHS/paediatrics referral; attach teacher rating scales if available
  • Support and environmental modifications first; parent training first-line under 5 (NICE NG87)
  • SENCO contact this week: SEND Support Plan now
Do not delay referral waiting for a school questionnaire
📊 2 — NICE NG87 Medication Pathway
Medication First-Line by Age
Under 5: NO medication. ADHD-specific parent training only.
Children 5–18: Methylphenidate MR first-line (Schedule 2). Lisdexamfetamine if MPH inadequate.
Adults 18+: Lisdexamfetamine or methylphenidate first-line; switch to the other if a 6-week trial is inadequate.
Anxiety/tics/misuse: Individualised specialist choice; atomoxetine or (CYP) guanfacine MR if stimulants fail or are not tolerated.
Key Clinical Distinctions
Zombie effect: Over-dosing → reduce dose, do not stop
Flat affect: Dose reduction, not drug cessation
Tics new/worse: Monitor; specialist advice if significant
Adult first-line: Lisdexamfetamine or methylphenidate
Anxiety: Specialist advice; slower titration — no drug universally preferred
CD prescriptions: valid 28 days; ≤30 days' treatment
≥2 settings
DSM-5 requirement — e.g. school AND home; school information where feasible
LDX or MPH
Adults: lisdexamfetamine or methylphenidate first-line — NICE NG87
28 days
Schedule 2 CD prescription validity; quantity ≤30 days' treatment; specialist initiates
4–6 weeks
Atomoxetine full effect — warn family not to stop early
6 months
BP/HR + height interval on all ADHD drugs (weight 3-monthly if ≤10)
No routine ECG
Cardiology advice before medication only if NICE cardiac red flags
76%
Heritability — screen both parents with ASRS-v1.1
60%
Childhood ADHD persisting into adulthood — transition planning from age 16
⚠ 3 — Safety-Netting & Monitoring
🔴 Zombie/flat affect on medication
"Flat affect = over-dosing. Contact us within 1 week. Reduce dose, do not stop. Do not stop stimulant abruptly."
💊 Cardiovascular symptoms
"Chest pain, racing/irregular heartbeat, fainting → stop medication; same-day contact with us."
🟠 Mood change (atomoxetine)
"Suicidal ideation or dramatic mood change on atomoxetine → stop immediately; A&E or same-day GP."
Follow-up timeline
6w
6–8 weeks: Referral; teacher scales; SENCO; parent training; PHQ-9/ASRS
Dx
Post-diagnosis: Shared care; first CD prescription; medication counselling
4w
4–6 weeks post-med: BP/HR; weight centile; mood; tics; appetite
6m
6-monthly: Height centile; BP/HR (weight 3-monthly if ≤10); annual specialist review
📌 Absence epilepsy: never start stimulants if staring spells present — neurology first
🚨 Do not miss: Absence epilepsy (mimics ADHD; paediatric neurology) · Bipolar disorder (stimulants can precipitate mania) · ACEs/trauma (mimics ADHD; trauma-informed approach) · School exclusion (GP advocacy letter urgently) · Significant undetected hearing/vision loss
🛡️ Safety rules: Never initiate methylphenidate without specialist diagnosis · Specialist initiates; GP maintains on shared care · CD Rx valid 28 days, ≤30 days' treatment · Cardiology advice if NICE cardiac red flags (no routine ECG) · Height 6-monthly, weight at NICE age intervals · Atomoxetine black-box: suicidal ideation monitoring first 12 weeks · Guanfacine: never stop abruptly
🎓
SCA Exam Quick Reference
ADHD SCA — Two Settings · Guilt · Medication Fear · Teacher Scales
Tasks · Relating to Others · Global Skills
▼expand
🕐 12-Minute Consultation Flow
0–1 min
Address Guilt First + Open Question
"Before I ask anything clinical, I want to say something important: ADHD is a neurodevelopmental condition. It is not caused by parenting, screens, or diet. Nothing you could have done differently."
Then open: "Tell me about Charlie — in both school and at home — what is he like and what has concerned you?"
Relating to OthersGlobal Skills
✗ Starting with "does he fidget?" · ✗ Missing parental guilt · ✗ Not confirming two settings from the start
1–4 min
Two Settings + Both Domains + ICE
"Are both the attention difficulties and the hyperactivity present in school AND at home — not just one setting?"
ICE: "What is your understanding of ADHD?" (ideas) / "What worries you most — the diagnosis or the medication?" (concerns) / "What were you hoping would happen today?" (expectations). Screen for absence epilepsy: "Any staring spells or blank episodes?"
TasksRelating to Others
✗ Single setting only · ✗ Not asking about absence epilepsy · ✗ Confirming food/screen myths
4–7 min
Medication Fear + Plain Language
"The zombie effect you've read about is actually a sign the dose is too high — at the right dose, most parents describe their child becoming more themselves. The medication helps the brain do what it was always trying to do."
Explain NICE NG87: support and environmental modifications first; medication is not automatic; specialist will discuss all options. Validate wanting to try without medication first.
TasksGlobal Skills
✗ Not addressing zombie concern specifically · ✗ Pressuring into medication · ✗ Not explaining the non-medication pathway
7–10 min
Referral + Teacher Scales + SENCO
"I am making the referral today. I would like you to take this rating scale to Charlie's teacher — it takes 10 minutes and makes the specialist appointment much more efficient. Please also contact the school SENCO this week — support doesn't have to wait."
Baseline measurements: BP, HR, height, weight centile. Do NOT initiate methylphenidate. ASRS for parent if time.
TasksRelating to Others
✗ Referring without teacher scales · ✗ Initiating methylphenidate · ✗ Not advising SENCO
10–12 min
Safety-Nets + Parent Wellbeing + Close
"If medication is later started and Charlie seems flat or unlike himself — that means the dose needs reducing, not stopping. Contact us within a week. Any chest pain or racing heartbeat: same-day contact."
"How are you both doing — and I noticed you mentioned some of these patterns in yourself. Would you like to do a brief questionnaire about your own attention?"
TasksGlobal Skills
✗ No safety-net for zombie effect · ✗ Not offering parental ADHD screen · ✗ No closing question
🔴🟠🟢 RAG — All 3 Domains
Tasks
🟢
Both DSM-5 domains; two settings; teacher scales requested; SENCO advised; baseline measurements; absence epilepsy screened; no MPH in primary care; non-medication pathway explained; ASRS offered; follow-up named
🟠
Two settings confirmed but teacher scales not requested; referral made but SENCO not mentioned; baseline measurements absent; absence epilepsy not screened; medication fear noted but not addressed
🔴
Parental guilt not addressed; single setting; teacher scales absent; methylphenidate initiated in primary care; medication fear not corrected; absence epilepsy missed; sugar/screen myths reinforced
Relating to Others
🟢
Guilt corrected emphatically; medication fear addressed accurately (zombie = overdosing); non-medication pathway validated; ICE all three; parent wellbeing named; ASRS offered; hopeful prognosis; closing question
🟠
Guilt acknowledged but not corrected; medication concern noted not addressed; ICE partial; parent wellbeing not asked; prognosis not given; consultation felt clinical not therapeutic
🔴
Guilt dismissed or ignored; medication fear worsened; no ICE; parent feels judged; no parental wellbeing; prognosis catastrophised
Global Skills
🟢
Guilt addressed first; open question before clinical screen; plain language (engine analogy); chunk-and-check; prognosis hopeful; closing question; structured in 12 minutes
🟠
Adequate structure but guilt not first; jargon used; no chunk-and-check; ran over time; consultation driven by clinical agenda
🔴
Led questions; opened clinically before addressing guilt; paternalistic; overwhelmed parent with information; no plain language; no structure
💬 Key Phrases
💭 Address parental guilt
"ADHD is a neurodevelopmental condition. It is not caused by parenting, screens, or diet. If Charlie has ADHD, there is nothing you could have done differently. Charlie has been trying his best the whole time."
😟 Correct the zombie myth
"The flat, zombie-like effect you have read about is a sign the dose is too high — not that the medication is wrong. At the right dose, most parents say their child becomes more themselves. The response to flat affect is dose reduction, not stopping."
🎯 Validate no-medication preference
"Wanting to try without medication first is a completely valid approach and a sensible first step: ADHD-focused support and changes at home and school come first, and medication is offered only if symptoms are still causing real problems. The specialist will discuss all options."
🏫 Teacher scales — key action
"Alongside the referral, it would help to get Charlie's teacher to complete this rating scale — it takes about 10 minutes. I will not hold the referral back waiting for it."
🔬 Plain language mechanism
"Think of the ADHD brain as having a difficulty with its own speed regulation — it can go brilliantly fast on things it loves, but struggles to maintain the right pace for less stimulating tasks. The medication helps the regulation system work more reliably."
💚 Parental ADHD screen
"You mentioned noticing some of these patterns in yourself — that is a very common experience for parents when a child is being assessed. Would you like to fill in a brief questionnaire? If your score is elevated, there is a pathway for adults too."
🚫 8 Danger Zones
✗
Parental guilt not addressed→ The most important therapeutic act in this consultation. ADHD is neurodevelopmental — explicitly clearing the parent's guilt changes their ability to engage with treatment. Omitting this is both clinically and humanistically incomplete.
✗
Teacher scales not requested→ DSM-5 requires two-setting confirmation and teacher observations help provide it — request them where feasible. But they are adjuncts, not NICE-mandated, and referral should never be delayed solely waiting for them.
✗
Methylphenidate initiated in primary care→ Schedule 2 CD; specialist diagnosis required first; Shared Care Agreement mandatory. Initiating methylphenidate without specialist assessment is a medico-legal error regardless of how clear the clinical picture appears.
✗
Medication fear not corrected→ The zombie effect is dose-dependent over-dosing. The correct response is dose reduction not stopping. A parent who leaves not understanding this will refuse consent for medication when it is recommended — preventing effective treatment.
✗
Absence epilepsy not screened→ Absence epilepsy mimics ADHD. Stimulants may lower seizure threshold. Staring spells, eye blinking, or brief unresponsive episodes must be asked about. If present: paediatric neurology before any ADHD management.
✗
Adults: assuming only one stimulant is first-line→ NICE NG87: lisdexamfetamine or methylphenidate is first-line for adults; in children methylphenidate is first-line and lisdexamfetamine second-line.
✗
Non-medication pathway not explained→ NICE NG87: support and environmental modifications before medication (parent training first-line under 5). A parent who believes medication is automatic will resist the whole pathway. The non-medication option is not a concession — in NICE NG87 medication at 5+ follows environmental modifications that have not been enough.
✗
Parental ADHD not screened→ 76% heritability. Parental ADHD directly impairs ability to implement behavioural strategies. ASRS-v1.1 is a 6-item validated screen that takes 2 minutes. Offering it is both diagnostically appropriate and therapeutically significant.
💊 Drug Quick-Pick by Scenario
Child 5–18, standard
→Methylphenidate MR (Concerta XL)
Specialist initiates; CD ≤30 days' treatment; growth at NICE intervals
Adult 18+
→Lisdexamfetamine (Elvanse)
NICE NG87 first-line option in adults (with MPH); 12–14h duration
Stimulants failed / not tolerated
→Atomoxetine (Strattera)
Non-stimulant; not a CD; takes 4–6 weeks; black-box mood
Child, stimulants failed (specialist)
→Guanfacine MR (Intuniv)
Non-stimulant; NICE NG87 option; sedation; taper off — never stop abruptly
MPH inadequate (child)
→Lisdexamfetamine (Elvanse)
Second-line children after 6 weeks inadequate MPH
ADHD sleep comorbidity
→Melatonin (Adaflex)
After sleep hygiene; check stimulant timing first; annual review
⛔ Specialist-initiated ONLY — never start methylphenidate or lisdexamfetamine in primary care · Adults: lisdexamfetamine or methylphenidate first-line — NICE NG87 · CD prescription valid 28 days, ≤30 days' treatment · Zombie effect = specialist dose review, not stop · Absence epilepsy: neurology before any stimulant · Atomoxetine: 4–6 weeks for effect — warn family; black-box suicidal ideation · Guanfacine: never stop abruptly · Growth monitoring at NICE intervals mandatory
Reviewed: July 2026 · citations verified against the primary sources listed